Application of Cluster Analysis of Time Evolution for Magnetic Resonance Imaging -Derived Oxygen Extraction Fraction Mapping: A Promising Strategy for the Genetic Profile Prediction and Grading of Glioma

Background: The intratumoral heterogeneity of oxygen metabolism and angiogenesis are core hallmarks of glioma, unveiling that genetic aberrations associated with magnetic resonance imaging (MRI) phenotypes may aid in the diagnosis and treatment of glioma.Objective: To explore the predictability of M...

Full description

Bibliographic Details
Main Authors:	Nanxi Shen, Shun Zhang, Junghun Cho, Shihui Li, Ju Zhang, Yan Xie, Yi Wang, Wenzhen Zhu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Neuroscience
Subjects:	oxygen extraction fraction (OEF) cluster analysis of time evolution dynamic contrast-enhanced MRI (DCE-MRI) multi-parameter MRI isocitrate dehydrogenase (IDH) O6-methylguanine-DNA methyltransferase (MGMT)
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2021.736891/full

Similar Items

Prediction of the Molecular Subtype of IDH Mutation Combined with MGMT Promoter Methylation in Gliomas via Radiomics Based on Preoperative MRI
by: Yongjian Sha, et al.
Published: (2023-02-01)

Beyond invasive biopsies: using VASARI MRI features to predict grade and molecular parameters in gliomas
by: Nurhuda Hendra Setyawan, et al.
Published: (2024-01-01)

Conventional MRI-Derived Biomarkers of Adult-Type Diffuse Glioma Molecular Subtypes: A Comprehensive Review
by: Paola Feraco, et al.
Published: (2022-10-01)

Prognostic genetic markers in malignant gliomas
by: Ralf Ketter, et al.
Published: (2010-12-01)

Rare Stochastic Expression of O6-Methylguanine- DNA Methyltransferase (MGMT) in MGMT-Negative Melanoma Cells Determines Immediate Emergence of Drug-Resistant Populations upon Treatment with Temozolomide In Vitro and In Vivo
by: Thomas C. Chen, et al.
Published: (2018-09-01)

Machine learning assisted DSC-MRI radiomics as a tool for glioma classification by grade and mutation status
by: Carole H. Sudre, et al.
Published: (2020-07-01)

Combination of the Distance From Tumor Edge to Subventricular Zone and IDH Mutation Predicts Prognosis of Patients With Glioma
by: Shuixian Zhang, et al.
Published: (2021-08-01)

Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations
by: Pasquale Persico, et al.
Published: (2022-02-01)

Temozolomide is additive with cytotoxic effect of irradiation in canine glioma cell lines
by: Nina Simona Tresch, et al.
Published: (2021-11-01)

Metabolic Rewiring in Adult-Type Diffuse Gliomas
by: Jong-Whi Park
Published: (2023-04-01)

Triple combination of lomustine, temozolomide and irradiation reduces canine glioma cell survival in vitro
by: Daniel Fuchs, et al.
Published: (2023-07-01)

Vessel Size Imaging is Associated with IDH Mutation and Patient Survival in Diffuse Lower-Grade Glioma
by: Kang H, et al.
Published: (2020-10-01)

The diagnostic value of ADC histogram and direct ADC measurements for coexisting isocitrate dehydrogenase mutation and O6-methylguanine-DNA methyltransferase promoter methylation in glioma
by: Zhiyan Xie, et al.
Published: (2023-01-01)

Radiomics Analysis Based on Magnetic Resonance Imaging for Preoperative Overall Survival Prediction in Isocitrate Dehydrogenase Wild-Type Glioblastoma
by: Shouchao Wang, et al.
Published: (2022-01-01)

Determining methylation status of methylguanine DNA methyl transferase (MGMT) from formalin-fixed, paraffin embedded tumor tissue
by: Francine B. de Abreu, et al.
Published: (2014-01-01)

Quantitative multiparametric MRI predicts response to neoadjuvant therapy in the community setting
by: John Virostko, et al.
Published: (2021-11-01)

T2 mapping of molecular subtypes of WHO grade II/III gliomas
by: Maike Kern, et al.
Published: (2020-01-01)

PET/MR Imaging of Somatostatin Receptor Expression and Tumor Vascularity in Meningioma: Implications for Pathophysiology and Tumor Outcomes
by: Michelle Roytman, et al.
Published: (2022-01-01)

Role of texture analysis and dynamic contrast-enhanced magnetic resonance imaging quantitative parameters based on different regions of interest in glioma grading
by: Peng-fei Zhao, et al.
Published: (2021-08-01)

Time-Efficient Perfusion Imaging Using DCE- and DSC-MRI
by: Macíček Ondřej, et al.
Published: (2018-10-01)

The value of CESM in the evaluation of intraductal breast papilloma: a comparative study with DCE-MRI
by: Rania Hegazy, et al.
Published: (2020-02-01)

Experimental study of selective MGMT peptides mimicking TMZ drug resistance in glioma
by: Yue Wu, et al.
Published: (2022-12-01)

Role of diffusion weighted imaging and dynamic contrast enhanced magnetic resonance imaging in breast tumors
by: Magda Ali Hany El Bakry, et al.
Published: (2015-09-01)

Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery
by: Patrick J. Cimino, et al.
Published: (2017-05-01)

Comparison of Ultrafast Dynamic Contrast-Enhanced (DCE) MRI with Conventional DCE MRI in the Morphological Assessment of Malignant Breast Lesions
by: Akane Ohashi, et al.
Published: (2023-03-01)

The diagnostic value of combined dynamic contrast-enhanced MRI (DCE-MRI) and diffusion-weighted imaging (DWI) in characterization of parotid gland tumors
by: Mohamed Ali EL-Adalany, et al.
Published: (2020-07-01)

O-6-methylguanine-DNA methyltransferase promoter methylation can change in glioblastoma recurrence due to intratumor heterogeneity
by: Valeria Barresi, et al.
Published: (2018-01-01)

Current Status of Biparametric MRI in Prostate Cancer Diagnosis: Literature Analysis
by: Mason James Belue, et al.
Published: (2022-05-01)

Associations of O6-methylguanine-DNA methyltransferase promoter methylation status with age and 1p/19q codeletion status in isocitrate dehydrogenase mutation gliomas based on an Asian cohort: A narrative review
by: Xu Wang, et al.
Published: (2022-01-01)

Promoter methylation analysis of IDH genes in human gliomas
by: Simon eFlanagan, et al.
Published: (2012-12-01)

Screening of Methylation Signature and Gene Functions Associated With the Subtypes of Isocitrate Dehydrogenase-Mutation Gliomas
by: XiaoYong Pan, et al.
Published: (2019-11-01)

Non-Invasive measurement of the cerebral metabolic rate of oxygen using MRI in rodents [version 4; peer review: 2 approved]
by: Eilidh MacNicol, et al.
Published: (2022-08-01)

The Association Between Pregnancy-Induced Hypertension and Neonatal Cerebral Metabolism, Hemodynamics, and Brain Injury as Determined by Physiological Imaging
by: Ying Qi, et al.
Published: (2022-02-01)

Multi-phasic CT versus dynamic contrast enhanced MRI in characterization of parotid gland tumors
by: Mohamed Metwally Abo El Atta, et al.
Published: (2016-12-01)

<i>IDH</i> Mutations in Glioma: Double-Edged Sword in Clinical Applications?
by: Alisan Kayabolen, et al.
Published: (2021-07-01)

Characterization of the Isocitrate Dehydrogenase Gene Family and Their Response to Drought Stress in Maize
by: Ningning Wei, et al.
Published: (2023-10-01)

Predictive Role of the Apparent Diffusion Coefficient and MRI Morphologic Features on IDH Status in Patients With Diffuse Glioma: A Retrospective Cross-Sectional Study
by: Jun Zhang, et al.
Published: (2021-05-01)

Utilization of functional MRI in the diagnosis and management of cervical cancer
by: Hirsch Matani, et al.
Published: (2022-11-01)

A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer Database
by: Amrit L. Pappula, et al.
Published: (2021-08-01)

Correlations of tumour permeability parameters with apparent diffusion coefficient in nasopharyngeal carcinoma
by: Alan W.L. Mui, et al.
Published: (2022-10-01)